Page last updated: 2024-08-16

sb 216995 and sb 203580

sb 216995 has been researched along with sb 203580 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, JL; Badger, AM; Boehm, JC; Bradbeer, J; Breton, JJ; Chabot-Fletcher, MC; Gallagher, TF; Garigipati, RS; Griswold, DE; Hillegass, LM; Laydon, JT; Lee, JC; Sheldrake, PL; Smietana, JM; Sorenson, ME1
Abdel-Meguid, S; Adams, JL; Boehm, JC; Canagarajah, BJ; Cobb, MH; Goldsmith, EJ; Kassisà, S; Wang, Z; Young, PR1
Abadleh, M; Kinkel, K; Laufer, S; Peifer, C; Schollmeyer, D1
Barlow, DJ; Ehrman, TM; Hylands, PJ1

Other Studies

4 other study(ies) available for sb 216995 and sb 203580

ArticleYear
1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.
    Journal of medicinal chemistry, 1996, Sep-27, Volume: 39, Issue:20

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arthritis; Bone Density; Cyclooxygenase Inhibitors; Cytokines; Imidazoles; Lipoxygenase Inhibitors; Mice; Mice, Inbred BALB C; Molecular Structure; Morpholines; Prostaglandin-Endoperoxide Synthases; Protein Kinases; Rats; Structure-Activity Relationship; Tumor Necrosis Factor-alpha

1996
Structural basis of inhibitor selectivity in MAP kinases.
    Structure (London, England : 1993), 1998, Sep-15, Volume: 6, Issue:9

    Topics: Adenosine Triphosphate; Calcium-Calmodulin-Dependent Protein Kinases; Catalytic Domain; Cell Differentiation; Cell Division; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Imidazoles; Kinetin; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Models, Chemical; Models, Molecular; p38 Mitogen-Activated Protein Kinases; Protein Conformation; Purines; Pyridines; Pyrimidines; Structure-Activity Relationship

1998
From five- to six-membered rings: 3,4-diarylquinolinone as lead for novel p38MAP kinase inhibitors.
    Journal of medicinal chemistry, 2007, Mar-22, Volume: 50, Issue:6

    Topics: Binding Sites; Crystallography, X-Ray; Heterocyclic Compounds, 4 or More Rings; Mitogen-Activated Protein Kinase 10; Models, Molecular; p38 Mitogen-Activated Protein Kinases; Quinolones; Structure-Activity Relationship

2007
In silico search for multi-target anti-inflammatories in Chinese herbs and formulas.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Anti-Inflammatory Agents; Crystallography, X-Ray; Cyclooxygenase 1; Cyclooxygenase 2; Databases, Factual; Drug Design; Drugs, Chinese Herbal; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Medicine, Chinese Traditional; Models, Chemical; Models, Molecular; Molecular Conformation; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase 4 Inhibitors; Structure-Activity Relationship

2010